| PERIOD ENDING | 31-Mar-09 | 31-Mar-08 | 31-Mar-07 | | Total Revenue | 14,250,900 | 9,126,200 | 7,692,000 | | Cost of Revenue | 13,206,300 | 7,193,800 | 6,112,500 | | | Gross Profit | 1,044,600 | 1,932,400 | 1,579,500 | | | Operating Expenses | | Research Development | 68,500 | 247,500 | 139,600 | | Selling General and Administrative | 1,306,200 | 1,092,800 | 826,600 | | Non Recurring | (893,300) |
-
|
-
| | Others | 552,800 |
-
|
-
| | | | Total Operating Expenses | 1,034,200 |
-
|
-
| | | | Operating Income or Loss | 10,400 | 592,100 | 613,300 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (449,100) | 203,000 | 124,700 | | Earnings Before Interest And Taxes | (507,000) | 795,100 | 738,000 | | Interest Expense | 674,700 | 262,500 | 125,600 | | Income Before Tax | (1,181,700) | 532,600 | 612,400 | | Income Tax Expense | 16,600 | 147,400 | 188,200 | | Minority Interest |
-
| (28,700) | (16,700) | | | | Net Income From Continuing Ops | (1,198,300) | 355,100 | 420,300 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | (1,198,300) | 355,100 | 420,300 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($1,198,300) | $355,100 | $420,300 |
|
0.20% Nasdaq 
Income Statement
